These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [A case of steroid-resistant polymyositis who made a good response to high dose intravenous immunoglobulins (IVIG)]. Saito M; Saito Y; Endo K; Tanaka M Rinsho Shinkeigaku; 2000 Feb; 40(2):181-3. PubMed ID: 10835943 [TBL] [Abstract][Full Text] [Related]
28. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis]. Tong SQ; Shi XH; Su JM; Zhao Y; Zhang FC Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):624-7. PubMed ID: 16681909 [TBL] [Abstract][Full Text] [Related]
29. Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis. Le Goff B; Chérin P; Cantagrel A; Gayraud M; Hachulla E; Laborde F; Papo T; Sibilia J; Zabraniecki L; Ravaud P; Puéchal X Arthritis Rheum; 2009 Jan; 61(1):108-18. PubMed ID: 19116970 [TBL] [Abstract][Full Text] [Related]
30. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis. Dalakas MC Neurology; 1998 Dec; 51(6 Suppl 5):S37-45. PubMed ID: 9851729 [TBL] [Abstract][Full Text] [Related]
31. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis. Lundberg I; Kratz AK; Alexanderson H; Patarroyo M Arthritis Rheum; 2000 Feb; 43(2):336-48. PubMed ID: 10693873 [TBL] [Abstract][Full Text] [Related]
33. Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis. Danieli MG; Calcabrini L; Calabrese V; Marchetti A; Logullo F; Gabrielli A Autoimmun Rev; 2009 Dec; 9(2):124-7. PubMed ID: 19386287 [TBL] [Abstract][Full Text] [Related]
34. Clinical spectrum of inflammatory myositis in South India--a ten year study. Porkodi R; Shanmuganandan K; Parthiban M; Madhavan R; Rajendran P J Assoc Physicians India; 2002 Oct; 50():1255-8. PubMed ID: 12568209 [TBL] [Abstract][Full Text] [Related]
35. [Intravenous immunoglobulins in polymyositis and dermatomyositis]. Chérin P; Herson S Rev Med Interne; 1999; 20 Suppl 4():436s-439s. PubMed ID: 10522319 [TBL] [Abstract][Full Text] [Related]
36. Muscle strength assessment in polymyositis and dermatomyositis evaluation of the reliability and clinical use of a new, quantitative, easily applicable method. Stoll T; Brühlmann P; Stucki G; Seifert B; Michel BA J Rheumatol; 1995 Mar; 22(3):473-7. PubMed ID: 7783064 [TBL] [Abstract][Full Text] [Related]
37. [Three patients with divergent presentations of idiopathic inflammatory myopathy]. Bronner IM; van der Meulen MF; Linssen WH; Hoogendijk JE; de Visser M Ned Tijdschr Geneeskd; 2002 May; 146(18):833-8. PubMed ID: 12038218 [TBL] [Abstract][Full Text] [Related]
38. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923 [TBL] [Abstract][Full Text] [Related]
39. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of oral manifestations and masticatory force in patients with polymyositis and dermatomyositis. Márton K; Hermann P; Dankó K; Fejérdy P; Madléna M; Nagy G J Oral Pathol Med; 2005 Mar; 34(3):164-9. PubMed ID: 15689230 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]